DVN
14
-6
PG
50
2
MDLZ
32
-4
WDC
37
-3
CHD
54
4
MCHP
34
-2
CMA
61
-3
USB
50
-3
CINF
53
3
ETN
75
-3
PEP
39
-9
ACN
47
-5
COST
57
-6
CMG
66
-4
HCA
48
-2
PDCO
29
2
CAG
24
-3
HAL
48
-3
EOG
56
-2
AIZ
82
2
DVN
14
-6
PG
50
2
MDLZ
32
-4
WDC
37
-3
CHD
54
4
MCHP
34
-2
CMA
61
-3
USB
50
-3
CINF
53
3
ETN
75
-3
PEP
39
-9
ACN
47
-5
COST
57
-6
CMG
66
-4
HCA
48
-2
PDCO
29
2
CAG
24
-3
HAL
48
-3
EOG
56
-2
AIZ
82
2
Financhill
Back

Amplify Weight Loss Drug & Treatment ETF Vs. Repligen Industry Stock Comparison

Sell
1

THNR
Amplify Weight Loss Drug & Treatment ETF

Last Price:
22.62
Seasonality Move:
--
Sell
30

RGEN
Repligen

Last Price:
123.01
Seasonality Move:
7.3%
Sell
1
Amplify Weight Loss Drug & Treatment ETF (THNR) is a Sell

Is Amplify Weight Loss Drug & Treatment ETF a Buy, Sell or Hold?

  • The current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $23.15. The Score for THNR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • THNR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THNR Stock Price Chart

What is Amplify Weight Loss Drug & Treatment ETF's stock price today?

  • The Amplify Weight Loss Drug & Treatment ETF share price today is $23.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

THNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 13.93 Sell
Chaikin Money Flow: -2437 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.6 - 26.34) Sell
Bollinger Bands (100): (25.51 - 27.37) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

THNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.43 Sell
20-day SMA: 25.21 Sell
50-day SMA: 26.22 Sell
200-day SMA: 0 Buy
8-day EMA: 24.32 Sell
20-day EMA: 25.04 Sell
50-day EMA: 25.81 Sell
200-day EMA: 7.77 Buy

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Amplify Weight Loss Drug & Treatment ETF Earnings Growth & THNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Amplify Weight Loss Drug & Treatment ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):